Selenium levels and Glutathione peroxidase activity in the plasma of patients with type II diabetes mellitus

• Published in: Journal of trace elements in medicine and biology Vol. 37; pp. 44 - 49
• Main Authors: González de Vega, Raquel, Fernández-Sánchez, María Luisa, Fernández, Juan Carlos, Álvarez Menéndez, Francisco Vicente, Sanz-Medel, Alfredo
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01-09-2016
• Subjects: Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - enzymology; Enzymatic activity; Glutathione peroxidase; Glutathione Peroxidase - blood; Humans; ICP-MS; Oxidative strees; Selenium - blood; Speciation; Glutathione peroxidase; Oxidative strees; ICP-MS; Enzymatic activity; Speciation
• ISSN: 0946-672X; 1878-3252
• DOI: 10.1016/j.jtemb.2016.06.007

Selenium, an essential trace element, is involved in the complex system of defense against oxidative stress through selenium-dependent glutathione peroxidases (GPx) and other selenoproteins. Because of its antioxidant properties, selenium or its selenospecies at appropriate levels could hinder oxidative stress and so development of diabetes. In this vein, quantitative speciation of selenium in human plasma samples from healthy and diabetic patients (controlled and non-controlled) was carried out by affinity chromatography (AF) coupled on-line to inductively coupled plasma mass spectrometry (ICP-MS) and isotope dilution analysis (IDA).
Similarly, it is well known that patients with diabetes who exhibit poor control of blood glucose show a decreased total antioxidant activity. Thus, we evaluated the enzymatic activity of GPx in diabetic and healthy individuals, using the Paglia and Valentine enzymatic method, observing a significant difference (p<0.05) between the three groups of assayed patients (healthy (n=24): 0.61±0.11U/ml, controlled diabetic (n=38): 0.40±0.12U/ml and non-controlled diabetic patients (n=40): 0.32±0.09U/ml). Our results show that hyperglycemia induces oxidative stress in diabetic patients compared with healthy controls. What is more, glycation of GPx experiments demonstrated that it is the degree of glycation of the selenoenzyme (another species of the Se protein) what actually modulates its eventual activity against ROS in type II diabetes mellitus patients.